volumes

Volume 5 - 2026

Original Research

Accepted on 05 Mar 2026

Complications and treatment patterns in patients with non-transfusion-dependent α-and β-thalassemia compared with matched controls: A retrospective observational study using administrative claims data in the United States

Arielle L. Langer
Amey Rane
Keely S. Gilroy
Jing Zhao
Louise Lombard
Carolyn R. Lew
Sujit Sheth

Frontiers in Hematology

Perspective

Accepted on 03 Mar 2026

Castleman Disease Mimicking Systemic Lupus Erythematosus: The Importance of Vigilance in Diagnosing Autoimmune Mimickers

Chao-chieh Cheng
Ruo-Han Chin
Po Cheng Shih
Su-Boon Yong
Chia-Jung Li

Frontiers in Hematology

Editorial

Accepted on 25 Feb 2026

The expanding role of cellular therapies in hematologic malignancies has fundamentally reshaped patient outcomes while reducing dependence on highly toxic cytotoxic chemotherapy. Within this framework, our research topic aims to underscore the evolving integration of immune and cellular therapy approaches into contemporary multiple myeloma (MM) management

Bhavana Bhatnagar
Srinivas Devarakonda

Frontiers in Hematology

Methods

Accepted on 23 Feb 2026

Single Spectral Flow Cytometry Panel for Simultaneous Detection of Hematopoietic Stem, Progenitor, and Mature Lineages in Mouse Bone Marrow

Léa Girondier
Manon Richaud
Julien Grenier
Ana Belen Perez Oliva
Jenny Van Asbeck-van der Wijst
Michel Aurrand-Lions
Maria De Grandis
Christophe Lachaud
Cyril Fauriat
Laura BRAUD

Frontiers in Hematology

Original Research

Accepted on 23 Feb 2026

Living with Chronic Lymphocytic Leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life

Kathryn Huntley
Alan J Poots
Sarah Gunn
Jan Rynne
Nick York
Sam Salek

Frontiers in Hematology

Case Report

Published on 23 Feb 2026

Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center

Andrew A. Y. Chen
Vivian T. Yin
Paula Blanco
Mark Trinder
Richard I. Crawford
Ryan Henrie
Stephen Parkin
Nasreen Khalil
Mollie Carruthers
Lu Zhang

Frontiers in Hematology

doi 10.3389/frhem.2026.1745884

494 views

Review

Published on 23 Feb 2026

The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis

Duygu Aydemir

Frontiers in Hematology

doi 10.3389/frhem.2026.1686097

262 views

Case Report

Published on 23 Feb 2026

Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

Emin Abdullayev
Markus Bieringer
Anna Ossami Saidy
Sefer Elezcurtaj
Wolfgang Schneider
Bertram Glaß
Snjezana Janjetovic

Frontiers in Hematology

doi 10.3389/frhem.2026.1776722

264 views

Case Report

Accepted on 12 Feb 2026

From Static Diagnosis to Clonal Kinetics: A New Framework for Timing Allogeneic Stem Cell Transplantation in Patients with Bone Marrow Failure Syndromes—A Hypothesis-Generating Case Series

na li
li huang

Frontiers in Hematology

Original Research

Published on 12 Feb 2026

Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

Gratial Theres Joseph
Sandeep Kumar Swain
Himanshu Dhanda
Neetu Kushwaha
Priti Kumari
Mahek Pravin Khushalani
Rakesh Kumar
Baseer Noor
Sufian Zaheer
Aditi Jain

Frontiers in Hematology

doi 10.3389/frhem.2026.1709697

589 views

Case Report

Published on 04 Feb 2026

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

Jiaxin Wu
Hongxiang Wang

Frontiers in Hematology

doi 10.3389/frhem.2026.1748301

532 views

Original Research

Published on 30 Jan 2026

Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

Vinny Lococo
Maire Okoniewski
Abdalla Shoaib
Leyla Shune
Sunil Abhyankar
Anurag Singh
Dennis Allin
Briha Ansari
Joseph McGuirk
Omar S. Aljitawi

Frontiers in Hematology

doi 10.3389/frhem.2026.1733667

1,200 views

Editorial

Published on 27 Jan 2026

Editorial: Innovations and challenges in sickle cell disease: bridging gaps in global health

Arturo José Martí-Carvajal

Frontiers in Hematology

doi 10.3389/frhem.2026.1787190

742 views

Volume 4 - 2025

Case Report

Published on 23 Jan 2026

Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

Guilherme Gasparini Spiandorelo
Ahmed Alnughmush
Olivia Crum
Dragan Jevremovic
J. C. Villasboas

Frontiers in Hematology

doi 10.3389/frhem.2025.1683981

1,032 views

Case Report

Published on 23 Jan 2026

Daratumumab in severe Evans syndrome: a case report

Stefan M. Hillmann
Hendrik Brockhoff
Sarah Loebel
Suna Hentschke
Dirk Arnold
Hans Salwender

Frontiers in Hematology

doi 10.3389/frhem.2025.1719208

1,009 views

Original Research

Published on 21 Jan 2026

Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia

Muluken Megiso
Chidiebube Ugwu
Elvis Obomanu
Alankrita Taneja

Frontiers in Hematology

doi 10.3389/frhem.2025.1730554

821 views

Systematic Review

Published on 15 Jan 2026

Outcomes of haploidentical hematopoietic stem cell transplantation in adults aged 60 and over: a systematic review and meta-analysis

Mohamed M. Khamis
Israa Ahmad Cheikh
Aleksandar Babic
Ranju Kunwor

Frontiers in Hematology

doi 10.3389/frhem.2025.1759405

1,029 views

Case Report

Published on 13 Jan 2026

Case Report: Luspatercept for transfusion-dependent anemia of unknown etiology

Simran Chandra
Vasu Bansal
Parth Sharma
Furha Cossor

Frontiers in Hematology

doi 10.3389/frhem.2025.1714544

959 views

Original Research

Published on 12 Jan 2026

Myeloma patients’ attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey

Eilidh M. Duncan
Silene ten Seldam
Xavier Leleu
Diane Loening-Martens
Charlotte Pawlyn
Séverine Wollenschneider
Katie Joyner
Kate Morgan

Frontiers in Hematology

doi 10.3389/frhem.2025.1699930

1,717 views

Review

Published on 08 Jan 2026

Targeting the JAK2V617F mutant hematopoietic microenvironment in myeloproliferative neoplasm

Amar Yeware

Frontiers in Hematology

doi 10.3389/frhem.2025.1694867

1,514 views

Review

Published on 07 Jan 2026

To treat or not to treat: a state-of-the-art overview of smoldering multiple myeloma

Ayushi Garg
Srinivas Devarakonda

Frontiers in Hematology

doi 10.3389/frhem.2025.1706219

1,299 views

Original Research

Published on 05 Jan 2026

Awareness, acceptability and factors associated with newborn screening for sickle cell disease among pregnant women in a Northern Nigerian Tertiary Hospital

Rabi’at Muhammad Aliyu
Niyi Mustapha Adebiyi
Yusuf Tabari Ibrahim
Ibrahim Halilu
Aliyu Dahiru Waziri
Isa Abdulkadir
Hafsat Rufai Ahmad

Frontiers in Hematology

doi 10.3389/frhem.2025.1717662

1,388 views

Systematic Review

Published on 03 Dec 2025

CRISPR–Cas9 mediated gene therapy in inherited bone marrow failure syndromes

Nadeesha J. S. Munugoda Hewa
Rajendra KC
Alex W. Hewitt
Kirsten A. Fairfax

Frontiers in Hematology

doi 10.3389/frhem.2025.1713610

1,961 views

Case Report

Accepted on 28 Nov 2025

A Converging Pathology: Chediak-Higashi Syndrome and IEI-Associated Lymphoproliferative Disease. Case Report

Carlos R Varón
Santiago Andrés Suárez-Gómez
Daniela Varón
Libelly Gomez Florez
Carolina Cortes
Elda Graciela Velez
Isabella Corona

Frontiers in Hematology

746 views